Patents by Inventor Michael R. Hamblin
Michael R. Hamblin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11135445Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.Type: GrantFiled: February 15, 2019Date of Patent: October 5, 2021Assignee: The General Hospital CorporationInventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Jeffrey A. Gelfand, Timothy Brauns
-
Publication number: 20200360043Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.Type: ApplicationFiled: July 7, 2020Publication date: November 19, 2020Inventors: Richard Rox Anderson, William A. Farinelli, Michael R. Hamblin, Dieter Manstein
-
Patent number: 10780294Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.Type: GrantFiled: November 18, 2015Date of Patent: September 22, 2020Assignee: The General Hospital CorporationInventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Jeffrey Gelfand, Timothy Brauns
-
Patent number: 10716591Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.Type: GrantFiled: October 17, 2017Date of Patent: July 21, 2020Assignee: The General Hospital CorporationInventors: Richard Rox Anderson, Michael R. Hamblin, Dieter Manstein, William A. Farinelli
-
Publication number: 20190175933Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.Type: ApplicationFiled: February 15, 2019Publication date: June 13, 2019Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Geoffrey Gelfand, Timothy Brauns
-
Publication number: 20180036029Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.Type: ApplicationFiled: October 17, 2017Publication date: February 8, 2018Inventors: Richard Rox ANDERSON, Michael R. HAMBLIN, Dieter MANSTEIN, William A. FARINELLI
-
Publication number: 20180036552Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.Type: ApplicationFiled: November 18, 2015Publication date: February 8, 2018Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Geoffrey Gelfand, Timothy Brauns
-
Patent number: 9827006Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.Type: GrantFiled: April 1, 2009Date of Patent: November 28, 2017Assignee: THE GENERAL HOSPITAL CORPORATIONInventors: Richard R. Anderson, Michael R. Hamblin, Dieter Manstein, William A. Farinelli
-
Publication number: 20130115133Abstract: The present invention relates the use of phenothiaziniums and microbial MDR inhibitors to inactivate microorganisms. Methods of the present invention are useful in the treatment of living subjects and in the decontamination of inanimate objects and substances.Type: ApplicationFiled: June 19, 2012Publication date: May 9, 2013Applicant: THE GENERAL HOSPITAL CORPORATIONInventors: Michael R. Hamblin, George P. Tegos
-
Publication number: 20120264802Abstract: The present invention relates to photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.Type: ApplicationFiled: May 31, 2012Publication date: October 18, 2012Applicants: Lynntech, Inc., The General Hospital CorporationInventors: Tim Wharton, Hariprasad Gali, Michael R. Hamblin
-
Patent number: 8207211Abstract: The present invention relates to photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.Type: GrantFiled: February 28, 2006Date of Patent: June 26, 2012Assignees: The General Hospital Corporation, Lynntech, Inc.Inventors: Tim Wharton, Hariprasad Gali, Michael R. Hamblin
-
Publication number: 20120041430Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.Type: ApplicationFiled: April 1, 2009Publication date: February 16, 2012Applicant: The General Hospital CorporationInventors: Richard R. Anderson, Michael R. Hamblin, Dieter Manstein, William A. Farinelli
-
Publication number: 20100184818Abstract: The present invention provides photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.Type: ApplicationFiled: April 15, 2008Publication date: July 22, 2010Applicants: THE GENERAL HOSPITAL CORPORATION, LYNNTECH, INC.Inventors: John Timothy Wharton, Hariprasad Gali, Michael R. Hamblin, Pawel Mroz
-
Publication number: 20090076115Abstract: The present invention relates to photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.Type: ApplicationFiled: February 28, 2006Publication date: March 19, 2009Applicants: The General Hospital Corporation, Lynntech, Inc.Inventors: Tim Wharton, Hariprasad Gali, Michael R. Hamblin
-
Publication number: 20080260650Abstract: The present invention relates to methods for the detection and therapy of inflamed tissue, whereby immune modulators are used to increase the uptake of diagnostic or therapeutic compositions by inflammatory cells.Type: ApplicationFiled: October 27, 2005Publication date: October 23, 2008Applicant: THE GENERAL HOSPITAL CorporationInventors: Ahmed Tawakol, Michael R. Hamblin, Raymond Q. Migrino, Jeffrey Gelfand
-
Publication number: 20080193376Abstract: The present invention relates to methods for the detection and therapy of active atheromatous plaques, and in particular vulnerable plaques, whereby immune modulators are used to increase the uptake of diagnostic or therapeutic compositions by the inflammatory cells associated with such plaques.Type: ApplicationFiled: October 28, 2004Publication date: August 14, 2008Applicant: The General Hospital CorporationInventors: Ahmed Tawakol, Michael R. Hamblin, Raymond Q. Migrino, Jeffrey Gelfand
-
Publication number: 20080166304Abstract: The present invention relates to the use of phenothiaziniums and microbial MDR inhibitors to inactivate microorganisms. Methods of the present invention are useful in the treatment of living subjects and in the decontamination of inanimate objects and substances.Type: ApplicationFiled: September 19, 2005Publication date: July 10, 2008Applicant: The General Hospital CorpoartionInventors: Michael R. Hamblin, George P. Tegos
-
Patent number: 7268155Abstract: Conjugate molecules which include photosensitizer compositions conjugated to non-antibody non-affinity pair targeting moieties and methods of making and using such conjugates are described.Type: GrantFiled: May 9, 2002Date of Patent: September 11, 2007Assignee: The General Hospital CorporationInventors: Tayyaba Hasan, Michael R. Hamblin, Nikos Soukos
-
Patent number: 7077839Abstract: Various tissue glues have drawback such as toxicity, causing inflammatory reactions or insufficient bonding strength. The present invention is directed to methods of form tissue adhesion by administering to tissues compositions comprising proteins conjugated to one or more novel photosensitizers and irradiating the composition. The composition may further comprise one or more proteins not conjugated to the photosensitizer. Additionally, the present invention relates to compositions and methods wherein increased ratios of protein to photosensitizer enhance weld strength.Type: GrantFiled: June 16, 2003Date of Patent: July 18, 2006Assignee: General Hospital CorporationInventors: Michael R. Hamblin, John Khadem
-
Publication number: 20030216718Abstract: Various tissue glues have drawback such as toxicity, causing inflammatory reactions or insufficient bonding strength. The present invention is directed to methods of form tissue adhesion by administering to tissues compositions comprising proteins conjugated to one or more novel photosensitizers and irradiating the composition. The composition may further comprise one or more proteins not conjugated to the photosensitizer. Additionally, the present invention relates to compositions and methods wherein increased ratios of protein to photosensitizer enhance weld strength.Type: ApplicationFiled: June 16, 2003Publication date: November 20, 2003Inventors: Michael R. Hamblin, John J. Khadem